These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9283291)

  • 21. Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.
    Torino D; Mollica A; Pinnen F; Feliciani F; Spisani S; Lucente G
    Bioorg Med Chem; 2009 Jan; 17(1):251-9. PubMed ID: 19081258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal and molecular structure of two geometrically restricted chemotactic tripeptides, analogues of formyl-methionine-leucine-phenylalanine.
    Michel AG; Lajoie G; Hassani CA
    Int J Pept Protein Res; 1990 Dec; 36(6):489-98. PubMed ID: 2090640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudopeptides containing the 2-hydrazonoacyl fragment: analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe.
    Torrini I; Nalli M; Paglialunga Paradisi M; Pagani Zecchini G; Lucente G; Spisani S
    J Pept Res; 2001 Jul; 58(1):56-66. PubMed ID: 11454170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.
    Lucente G; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2009 Jul; 37(2):285-95. PubMed ID: 18636221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New chemotactic peptide analogs with high biological activity for human neutrophils.
    Spisani S; Traniello S; Giuliani AL; Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Pochetti G; Lucente G
    Biochem Int; 1992 May; 26(6):1125-35. PubMed ID: 1321622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils.
    Cavicchioni G; Fraulini A; Turchetti M; Varani K; Falzarano S; Pavan B; Spisani S
    Eur J Pharmacol; 2005 Apr; 512(1):1-8. PubMed ID: 15814083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New fMLF-OMe analogues containing constrained mimics of phenylalanine residue.
    Torrini I; Mastropietro G; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Spisani S
    Arch Pharm (Weinheim); 1998 May; 331(5):170-6. PubMed ID: 9691248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing beta-alanine or taurine at the central position.
    Giordano C; Lucente G; Nalli M; Pagani Zecchini G; Paglialunga Paradisi M; Varani K; Spisani S
    Farmaco; 2003 Nov; 58(11):1121-30. PubMed ID: 14572863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hybrid alpha/beta-peptides: for-Met-Leu-Phe-OMe analogues containing geminally disubstituted beta2,2- and beta 3,3-amino acids at the central position.
    Mollica A; Paglialunga Paradisi M; Torino D; Spisani S; Lucente G
    Amino Acids; 2006 Jun; 30(4):453-9. PubMed ID: 16547648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of fMLP pocket dimensions and features using formyltetrapeptides.
    Cavicchioni G; Varani K; Niccoli S; Rizzuti O; Spisani S
    J Pept Res; 1999 Oct; 54(4):336-43. PubMed ID: 10532239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-peptido sulfonamides: for-Met-Leu-Phe-OMe analogues containing taurine and chiral beta-amino-ethanesulfonic acid residues.
    Giordano C; Nalli M; Paradisi MP; Sansone A; Lucente G; Spisani S
    Farmaco; 2004 Dec; 59(12):953-63. PubMed ID: 15598430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformationally restricted formyl methionyl tripeptide chemoattractants: a three-dimensional structure-activity study of analogs incorporating a C alpha,alpha-dialkylated glycine at position 2.
    Toniolo C; Crisma M; Valle G; Bonora GM; Polinelli S; Becker EL; Freer RJ; Sudhanand ; Rao RB; Balaram P
    Pept Res; 1989; 2(4):275-81. PubMed ID: 2520765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides.
    Torrini I; Zecchini GP; Paradisi MP; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1995 Apr; 35(4):347-58. PubMed ID: 7711275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformationally constrained formyl methionyl tripeptides: structure-function study of analogs containing alpha,beta-dehydrophenylalanine and dehydroleucine.
    Bharadwaj A; Singh M; Bhandary K; Becker EL; Chauhan VS
    Pept Res; 1993; 6(6):298-307. PubMed ID: 8292847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains.
    Lucente G; Paradisi MP; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2008 Aug; 35(2):329-38. PubMed ID: 18163179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational studies of synthetic tripeptide chemoattractants.
    Vertuani G; Spisani S; Boggian M; Traniello S; Scatturin A
    Int J Pept Protein Res; 1987 Apr; 29(4):525-32. PubMed ID: 3596903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues.
    Ferretti ME; Nalli M; Biondi C; Colamussi ML; Pavan B; Traniello S; Spisani S
    Cell Signal; 2001 Apr; 13(4):233-40. PubMed ID: 11306240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
    Cavicchioni G; Fraulini A; Falzarano S; Spisani S
    Bioorg Chem; 2006 Oct; 34(5):298-318. PubMed ID: 16919307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A conformation-activity study of the [L-(alpha Me)Phe]3 analog of the formyl methionyl tripeptide chemoattractant.
    Toniolo C; Crisma M; Pegoraro S; Valle G; Bonora GM; Becker EL; Polinelli S; Boesten WH; Schoemaker HE; Meijer EM
    Pept Res; 1991; 4(2):66-71. PubMed ID: 1815780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues.
    Fabbri E; Spisani S; Barbin L; Biondi C; Buzzi M; Traniello S; Zecchini GP; Ferretti ME
    Cell Signal; 2000 Jun; 12(6):391-8. PubMed ID: 10889468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.